Down's syndrome screening using free beta hCG: Instability can significantly increase the Down's risk estimate

被引:11
作者
Beaman, JM
Akhtar, N
Goldie, DJ
机构
[1] Department of Clinical Chemistry, Lewis Laboratories, Southmead Hospital
关键词
AFP; dual AFP/beta hCG assay; storage of blood samples;
D O I
10.1177/000456329603300606
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
The stability of free beta hCG (human chorionic gonadotrophin) was assessed using a dual alpha-fetoprotein and free beta hCG assay. A significant increase in free beta hCG concentration was observed in heparinized samples left unseparated for 24 h or more, the mean increase in 21 samples being 10.2% after 24 h (P = < 0.001), increasing to 45.7% after 96 h. Similar results were also obtained in clotted samples. The effect of the increase in free beta hCG on the Down's risk estimate was calculated to assess the impact of delayed sample transport and separation. The Down's risk increased in all samples with increasing separation time, but this was most significant in two samples where, using a cut off of one in 250, the risk classification changed from low risk to high risk. These results suggest that delayed sample separation can have a significant effect on screening programmes using free beta hCG, particularly with respect to those patients whose risk classification is changed.
引用
收藏
页码:525 / 529
页数:5
相关论文
共 14 条
[1]   MATERNAL SERUM-FREE BETA-HUMAN CHORIONIC-GONADOTROPIN LEVEL - THE EFFECT OF SAMPLE TRANSPORTATION [J].
CUCKLE, HS ;
JONES, RG .
ANNALS OF CLINICAL BIOCHEMISTRY, 1994, 31 :97-98
[2]  
Goldie D J, 1995, J Med Screen, V2, P207
[3]   MATERNAL SERUM DOWN-SYNDROME SCREENING - FREE BETA-PROTEIN IS A MORE EFFECTIVE MARKER THAN HUMAN CHORIONIC-GONADOTROPIN [J].
MACRI, JN ;
KASTURI, RV ;
KRANTZ, DA ;
COOK, EJ ;
MOORE, ND ;
YOUNG, JA ;
ROMERO, K ;
LARSEN, JW .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1990, 163 (04) :1248-1253
[4]   MATERNAL SERUM-FREE BETA-HCG SCREENING - RESULTS OF STUDIES INCLUDING 480 CASES OF DOWN-SYNDROME [J].
MACRI, JN ;
SPENCER, K ;
GARVER, K ;
BUCHANAN, PD ;
SAY, B ;
CARPENTER, NJ ;
MULLER, F ;
BOUE, A .
PRENATAL DIAGNOSIS, 1994, 14 (02) :97-103
[5]  
PETTERSON K, 1993, CLIN CHEM, V10, P2084
[6]   THE MATHEMATICAL BASIS OF MULTIVARIATE RISK SCREENING - WITH SPECIAL REFERENCE TO SCREENING FOR DOWNS-SYNDROME ASSOCIATED PREGNANCY [J].
REYNOLDS, TM ;
PENNEY, MD .
ANNALS OF CLINICAL BIOCHEMISTRY, 1990, 27 :452-458
[7]  
SANKEN U, 1995, PRENAT DIAGN, V15, P731
[8]   PROSPECTIVE-STUDY OF PRENATAL SCREENING FOR DOWNS-SYNDROME WITH FREE BETA-HUMAN CHORIONIC-GONADOTROPIN [J].
SPENCER, K ;
CARPENTER, P .
BRITISH MEDICAL JOURNAL, 1993, 307 (6907) :764-769
[9]   FREE BETA-HUMAN CHORIOGONADOTROPIN IN DOWNS-SYNDROME SCREENING - A MULTICENTER STUDY OF ITS ROLE COMPARED WITH OTHER BIOCHEMICAL MARKERS [J].
SPENCER, K ;
COOMBES, EJ ;
MALLARD, AS ;
WARD, AM .
ANNALS OF CLINICAL BIOCHEMISTRY, 1992, 29 :506-518
[10]  
SPENCER K, 1991, CLIN CHEM, V37, P809